CELPHARMA
ActiveSummary
The computed 12-month bankruptcy probability of CELPHARMA is 1.8% (moderate). The 2025 annual accounts show equity of €1.9m and a net result of €242,673. Its solvency ranks better than 55% of 6,139 sector peers (NACE 46, financial year 2025). The company has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals.
Register details
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 25 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.
Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.
Sites & property
2 establishment units
2 parcels
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 23094D0029/00R000 | Flanders | 4,801 m² | 1 · 1,270 m² | 18.4 m · 5 |
| 21822R0224/00P007 | Brussels | 1,301 m² | 1 · 811 m² | 32.5 m · 9 |